SLIDEX MENINGITE KIT 5 - ANVISA Registration nº 10158120198, Expiration of Registration: 19/12/2011, LOT NO .: 804114501, valid for lot: 12/21/2006. 의 안전성 경고

Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.

According to company information following the investigations and risk analysis, they concluded that the health impact is extremely low, as the etiological diagnosis of bacterial meningitis is based on a set of diagnostic tests and clinical evaluation. The symptoms are usually accompanied by antibiotic therapy. The Unit of Technovigilance - UTVIG / NUVIG / ANVISA is monitoring the actions of the company. ////////// In a letter dated December 20, 2006, the Company informs the closure of voluntary collection.